- Home
- FMAO vs IMAB Comparison
FMAO vs IMAB Comparison
Compare FMAO & IMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMAO
- IMAB
- Stock Information
- Founded
- FMAO 1897
- IMAB 2014
- Country
- FMAO United States
- IMAB United States
- Employees
- FMAO N/A
- IMAB N/A
- Industry
- FMAO Savings Institutions
- IMAB Biotechnology: Pharmaceutical Preparations
- Sector
- FMAO Finance
- IMAB Health Care
- Exchange
- FMAO Nasdaq
- IMAB Nasdaq
- Market Cap
- FMAO 358.1M
- IMAB 394.2M
- IPO Year
- FMAO N/A
- IMAB 2020
- Fundamental
- Price
- FMAO $23.68
- IMAB $5.77
- Analyst Decision
- FMAO
- IMAB Strong Buy
- Analyst Count
- FMAO 0
- IMAB 6
- Target Price
- FMAO N/A
- IMAB $7.50
- AVG Volume (30 Days)
- FMAO 20.6K
- IMAB 2.0M
- Earning Date
- FMAO 10-28-2025
- IMAB 11-02-2025
- Dividend Yield
- FMAO 3.83%
- IMAB N/A
- EPS Growth
- FMAO 38.39
- IMAB N/A
- EPS
- FMAO 2.16
- IMAB N/A
- Revenue
- FMAO $108,632,000.00
- IMAB N/A
- Revenue This Year
- FMAO $3.38
- IMAB N/A
- Revenue Next Year
- FMAO $6.39
- IMAB N/A
- P/E Ratio
- FMAO $10.71
- IMAB N/A
- Revenue Growth
- FMAO 13.86
- IMAB N/A
- 52 Week Low
- FMAO $20.88
- IMAB $0.60
- 52 Week High
- FMAO $34.15
- IMAB $6.79
- Technical
- Relative Strength Index (RSI)
- FMAO 41.51
- IMAB 61.98
- Support Level
- FMAO $22.89
- IMAB $4.32
- Resistance Level
- FMAO $25.06
- IMAB $6.79
- Average True Range (ATR)
- FMAO 0.92
- IMAB 0.66
- MACD
- FMAO -0.16
- IMAB 0.20
- Stochastic Oscillator
- FMAO 31.16
- IMAB 67.42
About FMAO Farmers & Merchants Bancorp Inc.
Farmers & Merchants Bancorp Inc is a holding company based in Ohio. The company is engaged in general commercial banking business. The activities of the company include commercial, agricultural and residential mortgages as well as consumer and credit card lending activities.
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).